{"title":"Aerobic exercise rehabilitation training alleviates skeletal muscle atrophy caused by heart failure in mice through the SIRT1/PGC-1α pathway.","authors":"Jiawei Zhang, Xiao Chen, Chunxiao Wan","doi":"10.1097/FJC.0000000000001722","DOIUrl":null,"url":null,"abstract":"<p><p>To investigate the potential effects of aerobic exercise rehabilitation training (AET) on the progression of myocardial infarction (MI) in a left anterior descending (LAD) coronary artery ligation model in mice, and to explore the underlying mechanisms.MI was induced in male C57BL/6 mice by ligating the LAD coronary artery. After one week rest, the mice underwent either adaptive ladder training or treadmill training for five consecutive days. The H9C2 cell model was used to simulate AngII-induced myocardial injury, cardiac function was assessed via echocardiography, and gastrocnemius muscle laminin expression was analyzed by immunofluorescence. Skeletal muscle-related gene expression was evaluated by immunoblotting, and the effects of AET on mitochondrial function were assessed using immunoblotting and commercial kits. Additionally, JC-1 staining was employed to examine mitochondrial dysfunction and further confirm the underlying mechanisms.AET significantly improves cardiac function in MI mice and could mitigate skeletal muscle atrophy in these mice. Further analysis revealed that activation of the SIRT1/ PGC-1α pathway by AET enhances mitochondrial function in MI mice. Additionally, SIRT1 activation was shown to alleviate skeletal muscle mitochondrial dysfunction induced by heart failure in vitro.AET can alleviate skeletal muscle atrophy induced by heart failure in mice through the SIRT1/PGC-1α pathway.</p>","PeriodicalId":15212,"journal":{"name":"Journal of Cardiovascular Pharmacology","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/FJC.0000000000001722","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
To investigate the potential effects of aerobic exercise rehabilitation training (AET) on the progression of myocardial infarction (MI) in a left anterior descending (LAD) coronary artery ligation model in mice, and to explore the underlying mechanisms.MI was induced in male C57BL/6 mice by ligating the LAD coronary artery. After one week rest, the mice underwent either adaptive ladder training or treadmill training for five consecutive days. The H9C2 cell model was used to simulate AngII-induced myocardial injury, cardiac function was assessed via echocardiography, and gastrocnemius muscle laminin expression was analyzed by immunofluorescence. Skeletal muscle-related gene expression was evaluated by immunoblotting, and the effects of AET on mitochondrial function were assessed using immunoblotting and commercial kits. Additionally, JC-1 staining was employed to examine mitochondrial dysfunction and further confirm the underlying mechanisms.AET significantly improves cardiac function in MI mice and could mitigate skeletal muscle atrophy in these mice. Further analysis revealed that activation of the SIRT1/ PGC-1α pathway by AET enhances mitochondrial function in MI mice. Additionally, SIRT1 activation was shown to alleviate skeletal muscle mitochondrial dysfunction induced by heart failure in vitro.AET can alleviate skeletal muscle atrophy induced by heart failure in mice through the SIRT1/PGC-1α pathway.
期刊介绍:
Journal of Cardiovascular Pharmacology is a peer reviewed, multidisciplinary journal that publishes original articles and pertinent review articles on basic and clinical aspects of cardiovascular pharmacology. The Journal encourages submission in all aspects of cardiovascular pharmacology/medicine including, but not limited to: stroke, kidney disease, lipid disorders, diabetes, systemic and pulmonary hypertension, cancer angiogenesis, neural and hormonal control of the circulation, sepsis, neurodegenerative diseases with a vascular component, cardiac and vascular remodeling, heart failure, angina, anticoagulants/antiplatelet agents, drugs/agents that affect vascular smooth muscle, and arrhythmias.
Appropriate subjects include new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects, application of drugs to gain novel insights into physiology or pathological conditions, clinical results with new and established agents, and novel methods. The focus is on pharmacology in its broadest applications, incorporating not only traditional approaches, but new approaches to the development of pharmacological agents and the prevention and treatment of cardiovascular diseases. Please note that JCVP does not publish work based on biological extracts of mixed and uncertain chemical composition or unknown concentration.